ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

VSee Health Announces Filing Second Quarter 2025 Results

SAN JOSE, CA, MA / ACCESS Newswire / October 17, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a leader in telehealth solutions, reported its financial results for the three months ended June 30, 2025 ("Second Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2024 ("Second Quarter 2024").

Highlights

  • Second Quarter 2025 revenue of $3.4 million, up 98% year-over-year

  • Second Quarter 2025 Gross profit margin increased from 45% to 47%

Liquidity and Cash Flow

Cash flow used in operations was $765,094 in the first six months of 2025, compared to $2,594,214 in the first six months of 2024. Cash flow used in investing activities was $15,466 for the first six months of 2025, compared to $16,390 in the first six months of 2024. Cash flow from financing activities was $746,040 in the first six months of 2025, compared to $3,597,841 in the first six months of 2024.

The integration of iDoc Telehealth has been challenging yet the rewards of robust revenue growth, expanded customer relationships and operational progress should provide comfort to shareholders and interested parties alike that the Company is on the right path. The Company's is experiencing more than 100% year-over-year revenue growth which has been largely driven by the acquisition of iDoc and the growth of the Company's telehealth service. With the consolidation of VSee Lab and iDoc platforms, aligning physician coverage, service offerings, and client delivery models the Company believes both revenue growth and operational efficiencies will deliver monumental operational improvements for the near future. Finally, new clients have provided strong revenue growth and expansion into new services has improved gross margins, management is not yet satisfied and is committed to build shareholder value.

"We are extremely proud of our team's execution during the exhausting acquisition process. Our growing revenue and improved operational efficiencies have laid the foundation for continued success, but we also understand that much work needs to be done to improve shareholder value. As we enter this next phase of growth, we are committed to providing products and services that will be in high demand, improve patient care, and bring efficiencies to service providers. We understand if we continue to improve our offerings the natural end result will be improved shareholder value. Although we are pleased with the results from the financial results reported in the 10Q for the period ended 06/30/2025, we also understand we have a tremendous amount of work ahead of us. We promise to deliver results our customers and shareholders will be proud of. We commit to work relentlessly until every aspect of our business and operations are out preforming expectations," said Dr. Milton Chen, and Dr. Imo Aisiku, Co-Chief Executive Officer of VSee Health.

"VSee Health is at the forefront of redefining how the government and hospitals deliver care virtually. Our operational execution and discipline position us well for long-term value creation and sustainable growth," Mr. Chen added.

About VSee Health

VSee Health (NASDAQ: VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States.

For more information, please visit www.vseehealth.com.

Forward-Looking Statements

Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of VSee Health's periodic and current filings with the SEC, which are also made available on VSee Health's website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.

Contact:

VSee Health
Anne Chang
media@vsee.com

VSee Investor Contact:
Milton Chen
VSee Health
investor@vsee.com

SOURCE: VSee Health, Inc.



View the original press release on ACCESS Newswire

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.